Related Experiment Video
Updated: Oct 19, 2025
09:51
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
1.1K
Targeting Chaperone-Mediated Autophagy for Disease Therapy
Wenming Li1, Juan Dou2, Jing Yang1
1Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Current Pharmacology Reports
|September 20, 2021
Summary
Targeting chaperone-mediated autophagy (CMA) offers a promising therapeutic strategy. Research shows CMA alterations are linked to diseases like neurodegeneration and cancer, suggesting CMA modulation could restore cellular balance.
Area of Science:
- Cellular Biology
- Molecular Medicine
- Autophagy Research
Background:
- Chaperone-mediated autophagy (CMA) is a selective lysosomal degradation pathway crucial for cellular homeostasis.
- CMA regulates protein quality control, bioenergetics, and cellular processes under physiological conditions.
- Dysregulation of CMA is increasingly implicated in various pathological conditions.
Purpose of the Study:
- To review the intricate relationship between CMA and disease pathogenesis.
- To explore therapeutic strategies targeting the CMA pathway for disease treatment.
- To highlight the potential of CMA modulation for restoring cellular balance.
Main Methods:
- Literature review of current research on CMA and disease.
- Analysis of CMA's role in cellular homeostasis and stress response.
- Synthesis of findings on CMA alterations in disease contexts.
Main Results:
- CMA acts as an adaptive mechanism during cellular stress.
- Disease-associated proteins can disrupt CMA function, contributing to pathogenesis.
- An expanding list of CMA substrates and regulators underscores its broad involvement in disease.
- Rectifying CMA alterations shows therapeutic potential for various diseases.
Conclusions:
- Alterations in CMA are prominent in neurodegenerative diseases and cancers.
- Targeting CMA presents a viable strategy to recover cellular homeostasis.
- Modulating CMA offers a potential therapeutic avenue for treating relevant diseases.
Related Concept Videos
01:27Autophagy
4.9K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.9K
01:36Delivery Pathways to the Lysosome
8.1K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.1K
01:18Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
01:22Lysosomal Hydrolases
4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
01:13The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K